journal cover

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis

Current Opinion in Rheumatology

Mar 2, 2010

Michael G Feely, J R O'Dell

Download from

Publisher
PubMed

Abstract

The present review will focus on the role of conventional disease-modifying antirheumatic drugs (DMARDs) in the current management of rheumatoid arthritis (RA). Over the past several decades, the treatment of RA has been revolutionized, not only by the development of highly effective bi...read more

Mentioned in this Paper

Antirheumatic Drugs, Disease-Modifying
Endpoint Determination
Cost Effectiveness
Rheumatoid Arthritis
Cancer Remission
Remission Induction
Rheumatology Specialty
Drug Costs
Biological Factors
Paper Details
References
  • References37
  • Citations8
1234
  • References37
  • Citations8
1

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Human Vascular Endothelial Cell Atlas: Young & Old

Examining the genomics, transcriptomics, proteomics and metabolomics of the human vascular endothelial cells at the single cell level will help build a single cell atlas of human vascular endothelium, which would give a unique ID card for each cell type, a three-dimensional map of how cell types work together to form tissues and insights into how changes in the map underlie health and disease of the vascular endothelium from young to old age. Disocver the latest research on the single cell atlas of human vascular endothelial cell atlas here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Telomere Dysfunction

Telomere dysfunction in response to critical telomere shortening induces dna damage checkpoints that lead to cell cycle arrest and/or cell death.

Incretin & Type 1 Diabetes

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Allen Institute for Brain Science Network (MDS)

The Allen Institute for Brain Science Network is a not-for-profit biomedical research organization that provides open access to multiple neuroscience tools and resources. Find the latest research from tjr Allen Institute for Brain Science Network here.

Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the SARS coronavirus (SARS-CoV). Initial symptoms are flu-like and may include fever, muscle pain, lethargy symptoms, cough, sore throat, and other nonspecific symptoms. SARS may eventually lead to shortness of breath and pneumonia; either direct viral pneumonia or secondary bacterial pneumonia. DIscover the latest research on SARS here.

Computation Neuroscience - Preprints (MDS)

Computation neuroscience employs models, statistics, simulations, and theoretical analyses to understand mechanisms that govern neural functions. Here are the latest preprints in this domain.

LRRK2 & Immunity During Infection (MDS)

Mutations in the LRRK2 gene are a risk-factor for developing Parkinson’s disease. However, LRRK2 has been shown to function as a central regulator of vesicular trafficking, infection, immunity, and inflammation. Here is the latest research on the role of this kinase on immunity during infection.

Related Papers

Best Practice & Research. Clinical Rheumatology

Treatment of early rheumatoid arthritis

Best Practice & Research. Clinical RheumatologyAugust 14, 2003
Robin Geletka, E W St Clair
© 2020 Meta ULC. All rights reserved

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis

Current Opinion in Rheumatology

Mar 2, 2010

Michael G Feely, J R O'Dell

PMID: 20190639

DOI: 10.1097/bor.0b013e3283383f87

Abstract

The present review will focus on the role of conventional disease-modifying antirheumatic drugs (DMARDs) in the current management of rheumatoid arthritis (RA). Over the past several decades, the treatment of RA has been revolutionized, not only by the development of highly effective bi...read more

Mentioned in this Paper

Antirheumatic Drugs, Disease-Modifying
Endpoint Determination
Cost Effectiveness
Rheumatoid Arthritis
Cancer Remission
Remission Induction
Rheumatology Specialty
Drug Costs
Biological Factors

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Human Vascular Endothelial Cell Atlas: Young & Old

Examining the genomics, transcriptomics, proteomics and metabolomics of the human vascular endothelial cells at the single cell level will help build a single cell atlas of human vascular endothelium, which would give a unique ID card for each cell type, a three-dimensional map of how cell types work together to form tissues and insights into how changes in the map underlie health and disease of the vascular endothelium from young to old age. Disocver the latest research on the single cell atlas of human vascular endothelial cell atlas here.

Related Papers

Best Practice & Research. Clinical Rheumatology

Treatment of early rheumatoid arthritis

Best Practice & Research. Clinical RheumatologyAugust 14, 2003
Robin Geletka, E W St Clair
Paper Details
References
  • References37
  • Citations8
1234
  • References37
  • Citations8
1

Download from

Publisher
PubMed
/papers/update-on-the-use-of-conventional-disease-modifyin/20190639